FDA Inspection
Huntingdon Life Sciences, Inc.Huntingdon Life Sciences, Inc. – FDA Inspection, Sep 27, 2017
Record Details
This FDA Inspection record concerns Huntingdon Life Sciences, Inc., with an inspection on September 27, 2017, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 88197b85-5267-4221-8393-4d924072af4c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026747
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 58.130(a)Conduct: in accordance with protocol
- 21 CFR 58.185(a)Final report: non-existent
- 21 CFR 58.35(b)(5)QAU: authorize deviations from protocols or SOPs
- 21 CFR 58.35(b)(6)QAU: review final study report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Huntingdon Life Sciences, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2023 | Not classified | New Jersey District Office | |
| November 30, 2016 | VAI | New Jersey District Office | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Huntingdon Life Sciences, Inc.
- FDA Inspection 1215898 - 2023-08-01
- FDA Inspection 996465 - 2016-11-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.